1. Home
  2. BZAI vs VRXA Comparison

BZAI vs VRXA Comparison

Compare BZAI & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blaize Holdings Inc.

BZAI

Blaize Holdings Inc.

HOLD

Current Price

$1.34

Market Cap

268.9M

Sector

N/A

ML Signal

HOLD

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$2.05

Market Cap

288.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BZAI
VRXA
Founded
2010
N/A
Country
United States
Switzerland
Employees
254
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
288.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZAI
VRXA
Price
$1.34
$2.05
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.67
N/A
AVG Volume (30 Days)
3.9M
998.4K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$239.02
N/A
Revenue Next Year
$45.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.70
52 Week High
$6.76
$4.50

Technical Indicators

Market Signals
Indicator
BZAI
VRXA
Relative Strength Index (RSI) 41.07 10.34
Support Level $1.03 N/A
Resistance Level $1.57 N/A
Average True Range (ATR) 0.12 0.50
MACD -0.01 -0.20
Stochastic Oscillator 2.63 10.36

Price Performance

Historical Comparison
BZAI
VRXA

About BZAI Blaize Holdings Inc.

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: